AEGiS-ST: World record for testing Sunday Times (Johannesburg)Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to Sunday Times (Johannesburg) main menu
DonateNow
Print this article

World record for testing

Sunday Times - Sunday, 30 November, 2003
Janette Bennett


BMW South Africa knows all about setting new standards - in productivity and export volumes, for instance. But this is the record MD Ian Robertson holds particularly close to his heart: 85% of employees have undergone voluntary counselling and testing (VCT) for HIV.

That uptake is higher than any figure recorded by any other company anywhere in the world, and it has been acknowledged as such by the World Economic Forum's Global Health Initiative. In July, BMW SA's programme was highly commended as a best practice by the Global Business Coalition on HIV and Aids, an alliance of businesses in 178 countries.

In just 20 months, 2,611 of about 3,000 employees at BMW SA's Rosslyn manufacturing plant outside Pretoria and its Midrand head office have chosen to know their HIV status. The target is 100%.

"No one is anywhere near our level of testing as far as I know," Robertson says. "The exception may be cases of anonymous testing, which give a statistic and a risk analysis, but do not allow the company to do anything about it."

Voluntary counselling and testing, as opposed to compulsory or anonymous testing, enables the employee to actively take control of his or her health and enables the company to offer holistic care and support to HIV-positive employees.

Robertson, a board member of the South African Business Coalition on HIV/Aids, helped his company's VCT campaign kick off in April last year by being publicly tested. He remains integrally involved and has personally helped to roll out the programme to BMW suppliers and dealers.

The norm, for many companies, is to hive off their HIV/Aids programme to a specific department, with executives rarely knowing what is happening.

"It's not a public relations or human resources issue," Robertson says. "It's an issue that is fundamental to the success of our company. We treat HIV/Aids as we treat any other business challenge. It is very much part of our business, and all our managers address it as that."

He's also aware that if the top person in an organisation is seen to put his or her weight behind an issue, it is far more likely to be taken seriously. "I have ultimate responsibility for the ongoing success of this business, and the way we handle HIV/Aids is part of that. More importantly, I have responsibility for my people, and that extends beyond work."

In 2001, it cost BMW about R500,000 to implement its HIV/Aids strategy - which shows that it doesn't demand piles of money to get it right. "The costs of not facing HIV/Aids are far higher," Robertson says.

"Anyway, costs are dropping as drug prices drop and treatments become more successful. Money is not the issue - there are hundreds of millions of dollars out there for Aids programmes. The issue is capacity and the wherewithal to spend the money, and the passion to do something about it.

"Even on capacity, there is plenty of guidance available. The coalition, for one, has developed a tool kit on how to do it.

"Unfortunately, too many companies put [HIV/Aids] into the too-hard-to-handle pile. I'm staggered when I see some of the statistics on what is not happening in South Africa, how few companies even have programmes in place."

VCT is one important part of BMW's multi-pronged HIV/Aids programme. It began in 2000 with a knowledge, attitudes and practices study, conducted by the University of Pretoria. "It showed very high levels of awareness and knowledge, which was a good foundation on which to build," Robertson says.

An awareness campaign followed, focusing on practicalities, for instance, negotiating condom use with a partner.

A team made up with people from human resources, the trade unions, medical practitioners and management, was appointed to drive the process under the chairmanship of a senior board member. A smaller working group which reports to the board manages ongoing initiatives and activities.

The company knows some 30,000 condoms are distributed every month from 100 condom dispensers managed by two publicly declared HIV-positive people. This is roughly 10 condoms per employee, compared with just three a person six months ago.

The programme's broad aims are to reduce the impact of the disease on employees, their families and the company. It focuses on self-responsibility and taking ownership of the disease by knowing one's HIV status, hence the focus on testing.

It is also targeted at specific groups, such as women, whose physiology and socioeconomic position make them more likely than men to contract HIV. A women's forum is in place.

An important aspect is peer education. Sixty volunteers have been trained as peer educators, who provide support and information to their colleagues.
031130
ST031109


Copyright © 2003 - The Sunday Times. Reproduction of this article (other than one copy for personal reference) must be cleared through the Sunday Times Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .